1221 related articles for article (PubMed ID: 19463339)
1. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
[TBL] [Abstract][Full Text] [Related]
2. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction.
Chia S; Nagurney JT; Brown DF; Raffel OC; Bamberg F; Senatore F; Wackers FJ; Jang IK
Am J Cardiol; 2009 Feb; 103(3):333-7. PubMed ID: 19166685
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty.
Tzivoni D; Koukoui D; Guetta V; Novack L; Cowing G;
Am J Cardiol; 2008 Mar; 101(6):753-7. PubMed ID: 18328834
[TBL] [Abstract][Full Text] [Related]
4. Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
Byrne RA; Ndrepepa G; Braun S; Tiroch K; Mehilli J; Schulz S; Schömig A; Kastrati A
Am J Cardiol; 2010 Nov; 106(9):1212-7. PubMed ID: 21029815
[TBL] [Abstract][Full Text] [Related]
5. Assessment of left ventricle diastolic function in myocardial infarction patients treated with primary angioplasty.
Misztal M; Stopyra K; Gackowski A; Zmudka K; Piwowarska W
Cardiol J; 2009; 16(5):440-6. PubMed ID: 19753523
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
[TBL] [Abstract][Full Text] [Related]
7. Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial).
Dohi T; Maehara A; Brener SJ; Généreux P; Gershlick AH; Mehran R; Gibson CM; Mintz GS; Stone GW
Am J Cardiol; 2015 Mar; 115(5):563-70. PubMed ID: 25586335
[TBL] [Abstract][Full Text] [Related]
8. The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality.
Hartman MHT; Eppinga RN; Vlaar PJJ; Lexis CPH; Lipsic E; Haeck JDE; van Veldhuisen DJ; van der Horst ICC; van der Harst P
Clin Cardiol; 2017 May; 40(5):322-328. PubMed ID: 28026027
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity troponin T for prediction of left ventricular function and infarct size one year following ST-elevation myocardial infarction.
Reinstadler SJ; Feistritzer HJ; Klug G; Mair J; Tu AM; Kofler M; Henninger B; Franz WM; Metzler B
Int J Cardiol; 2016 Jan; 202():188-93. PubMed ID: 26397408
[TBL] [Abstract][Full Text] [Related]
10. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
[TBL] [Abstract][Full Text] [Related]
11. Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction.
Nienhuis MB; Ottervanger JP; Dambrink JH; de Boer MJ; Hoorntje JC; Gosselink AT; Suryapranata H; van 't Hof AW
Coron Artery Dis; 2009 Jan; 20(1):9-14. PubMed ID: 19050596
[TBL] [Abstract][Full Text] [Related]
12. Utility of CMR Markers of Myocardial Injury in Predicting LV Functional Recovery: Results from PROTECTION AMI CMR Sub-study.
Grover S; Bell G; Lincoff M; Jeorg L; Madsen PL; Huang S; Leow S; Figtree G; Chakrabarty A; Leong DP; Woodman RJ; Selvanayagam JB
Heart Lung Circ; 2015 Sep; 24(9):891-7. PubMed ID: 25846255
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
Jang IK; Pettigrew V; Picard MH; Kowey PR; Demmel V; Zile MR; Tatsuno J; Wackers FJ; Hibberd M
J Thromb Thrombolysis; 2005 Dec; 20(3):147-53. PubMed ID: 16261287
[TBL] [Abstract][Full Text] [Related]
15. Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial).
Daaboul Y; Korjian S; Weaver WD; Kloner RA; Giugliano RP; Carr J; Neal BJ; Chi G; Cochet M; Goodell L; Michalak N; Rusowicz-Orazem L; Alkathery T; Allaham H; Routray S; Szlosek D; Jain P; Gibson CM
Am J Cardiol; 2016 Sep; 118(5):625-31. PubMed ID: 27392509
[TBL] [Abstract][Full Text] [Related]
16. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
Hassan AK; Bergheanu SC; Hasan-Ali H; Liem SS; van der Laarse A; Wolterbeek R; Atsma DE; Schalij MJ; Jukema JW
Am J Cardiol; 2009 Mar; 103(6):779-84. PubMed ID: 19268731
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance.
Di Chiara A; Dall'Armellina E; Badano LP; Meduri S; Pezzutto N; Fioretti PM
J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):587-92. PubMed ID: 20588136
[TBL] [Abstract][Full Text] [Related]
19. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
[TBL] [Abstract][Full Text] [Related]
20. ST-segment analysis to predict infarct size and functional outcome in acute myocardial infarction treated with primary coronary intervention and adjunctive abciximab therapy.
Sciagrà R; Parodi G; Migliorini A; Valenti R; Antoniucci D; Sotgia B; Pupi A
Am J Cardiol; 2006 Jan; 97(1):48-54. PubMed ID: 16377283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
